ABRDN PLC – AbbVie Inc. Transaction History
ABRDN PLC portfolio value:
$384.84M
portfolio value
ABRDN PLC quarter portfolio value change:
-12.37%
quarter
AbbVie Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -5.30% | -160.38K shares | -78.35M | $134.21 | 2.86M |
Q2 2022 | share | Decrease | -16.11% | -581.52K shares | -130.34M | $153.16 | 3.02M |
Q1 2022 | share | Decrease | -25.65% | -1.24M shares | -63.79M | $162.11 | 3.60M |
Q4 2021 | share | Increase | +3.79% | 177.49K shares | 145.57M | $135.93 | 4.85M |
Q3 2021 | share | Decrease | -0.74% | -34.80K shares | -19.00M | $106.6 | 4.67M |
Q2 2021 | share | Increase | 0.00% | 4.71M shares | 530.77M | $110.09 | 4.71M |
Q1 2021 | share | Increase | +5.94% | 256.07K shares | 32.32M | $104.49 | 4.56M |
Q4 2020 | share | Increase | +4.50% | 185.64K shares | 100.59M | $102.27 | 4.31M |
Q3 2020 | share | Decrease | -3.83% | -164.31K shares | -59.82M | $82.47 | 4.12M |
Q2 2020 | share | Increase | +9.09% | 357.37K shares | 121.57M | $91.35 | 4.29M |
Q1 2020 | share | Increase | +75.63% | 1.69M shares | 101.38M | $69.88 | 3.93M |
Q4 2019 | share | Increase | +2.44% | 53.40K shares | 32.74M | $80.14 | 2.23M |
Q3 2019 | share | Increase | +127.48% | 1.22M shares | 95.65M | $67.55 | 2.18M |
Q2 2019 | share | Increase | +7.50% | 67.08K shares | -2.16M | $63.9 | 960.96K |
Q1 2019 | share | Increase | +15.56% | 120.38K shares | 2.49M | $69.89 | 893.88K |
Q4 2018 | share | Decrease | -6.12% | -50.44K shares | -8.40M | $78.96 | 773.50K |
Q3 2018 | share | Decrease | -21.19% | -221.53K shares | -18.96M | $80.16 | 823.94K |
Q2 2018 | share | Decrease | -62.35% | -1.73M shares | -165.91M | $77.74 | 1.04M |
Q1 2018 | share | Increase | +3.08% | 83.07K shares | 1.89M | $78.6 | 2.77M |
Q4 2017 | share | Increase | +34.86% | 696.25K shares | 83.43M | $79.74 | 2.69M |
Q3 2017 | share | Increase | 0.00% | 1.99M shares | 177.49M | $72.76 | 1.99M |